Tag: Palantir

Browse our exclusive articles!

Palantir’s AI Advantage Holds Strong Amid Downgrade, Analyst Slashes Price Target

Despite a recent downgrade, Palantir's AI advantage remains strong, positioning the company for long-term growth in the tech industry.

Ukraine’s Prosecutor General Uses Technology to Pursue War Crimes

Ukraine's Prosecutor General utilizes technology to pursue war crimes and human rights violations committed by Russian troops. Learn how they leverage innovative methods and partnerships for justice.

C3.ai’s Lackluster Growth and Competition Threatens its AI Leadership Position

Discover why C3.ai, a leading AI company, is facing challenges in the industry and why investors may want to consider alternative AI investments. Find out more.

US Tech Entrepreneurs Revolutionize Ukrainian Warfare with AI and Surveillance, Ukraine

Discover how US tech entrepreneurs revolutionize Ukrainian warfare with AI and surveillance, enhancing military capabilities against Russian forces. Read more!

Palantir Stock to Surge 54% as AI Fortress Propels Company in Next Decade, Says Analyst

Palantir, backed by CIA's In-Q-Tel, set for AI growth. Stock projected to surge 54%. Don't miss the opportunity.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img